Genentech Posts $931 Million 4Q Profit

SUGAR LAND--January 21, 2009--Researched by Industrial Info Resources (Sugar Land, Texas)--Genentech Incorporated (NYSE:DNA) (San Francisco, California) recently announced a fourth-quarter 2008 net income of $931 million, up 47% compared with $632 million in the same period of 2007. Sales for the quarter rose 13% to $2.5 billion, compared with $2.2 billion in the fourth quarter of 2007. Industrial Info is tracking two active Genentech projects worth $300 million as part of our Pharmaceutical Tracker - Online Database. The larger of the two projects is a grassroot biotherapeutic fill and finish plant in Hillsboro, Oregon. Hillsboro is one of three locations that Genentech has targeted to ramp up manufacturing, Chairman and CEO Arthur Levinson said.